The DOI matches its Crossref record; 475 of the 475 references it cites were found in a registry or an index.
Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration
Open accessAbstract
Adenosine acts in parallel as a neuromodulator and as a homeostatic modulator in the central nervous system. Its neuromodulatory role relies on a balanced activation of inhibitory A(1) receptors (A1R) and facilitatory A(2A) receptors (A2AR), mostly controlling excitatory glutamatergic synapses: A1R impose a tonic brake on excitatory transmission, whereas A2AR are selectively engaged to promote synaptic plasticity phenomena. This neuromodulatory role of adenosine is strikingly similar to the role of adenosine in the control of brain disorders; thus, A1R mostly act as a hurdle that needs to be overcame to begin neurodegeneration and, accordingly, A1R only effectively control neurodegeneration if activated in the temporal vicinity of brain insults; in contrast, the blockade of A2AR alleviates the long-term burden of brain disorders in different neurodegenerative conditions such as ischemia, epilepsy, Parkinson's or Alzheimer's disease and also seem to afford benefits in some psychiatric conditions. In spite of this qualitative agreement between neuromodulation and neuroprotection by A1R and A2AR, it is still unclear if the role of A1R and A2AR in the control of neuroprotection is mostly due to the control of glutamatergic transmission, or if it is instead due to the different homeostatic roles of these receptors related with the control of metabolism, of neuron-glia communication, of neuroinflammation, of neurogenesis or of the control of action of growth factors. In spite of this current mechanistic uncertainty, it seems evident that targeting adenosine receptors might indeed constitute a novel strategy to control the demise of different neurological and psychiatric disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Gage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 4,786
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Springer eBooks · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,962
Research works printed but not linked: 3
- Porciúncula, 2006, Blockade of adenosine A 2A receptors differently alters convulsive behaviour and prevents hippocampal damage in two models of temporal lobe epilepsy, Purinergic Signal, 2, 134
- Fernandez, 2008, .U.-C.I. Group, The safety and efficacy of istradephylline, an adenosine A2A antagonist, as monotherapy in Parkinson's disease: results of the KW-6002-US-051 trial, Mov. Disord., 23, S87
- Kaster, 2010, Genetic or pharmacological blockade of adenosine A2A receptors prevents behavioral and morphological effects of chronic stress in mice, Purinergic Signal, 6, S93
Cited by
Sorted by citations
Items 101–200 of 425
Akomolafe, S. F., Olasehinde, T. A., Oyeleye, S. I., Aluko, B. T., Adewale, O. O., & Ijomone, O. M. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00205-0 · Cited by 47
Ena, S., Backer, J. D., Schiffmann, S. N., & d’Exaerde, A. D. K. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2989-12.2013 · Cited by 43
From poly(alkyl cyanoacrylate) to squalene as core material for the design of nanomedicines
Mura, S., Fattal, E., & Nicolas, J. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1579822 · Cited by 45
Astrocytes and Adenosine A2A Receptors: Active Players in Alzheimer’s Disease
Lopes, C. R., Cunha, R. A., & Agostinho, P. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.666710 · Cited by 47
Self-citationWong, R., & Schlichter, L. C. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2014.11.711 · Cited by 43
Porciúncula, L. O., Sallaberry, C., Mioranzza, S., Botton, P. H. S., & Rosemberg, D. B. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.09.009 · Cited by 45
Varani, K., Vincenzi, F., Merighi, S., Gessi, S., & Borea, P. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_61 · Cited by 43
Chen, S., Lin, M., Tsai, J.-S., He, P., Luo, W.-T., Chiu, I.-M., Herschman, H. R., & Li, H. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0174 · Cited by 43
Guanosine monophosphate reductase 1 is a potential therapeutic target for Alzheimer’s disease
Liu, H., Luo, K., & Luo, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-21256-6 · Cited by 42
García‐Berrocoso, T., Llombart, V., Campàs, L. C., Hainard, A., Licker, V., Peñalba, A., Ramiro, L., Simats, A., Bustamante, A., Martínez-Sáez, E. A., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000419 · Cited by 42
Huo, M., Wang, Z., Fu, W., Lu, T., Li, W., Zhou, Z., Chen, Y., Wei, J., & Abliz, Z. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00179 · Cited by 43
Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells
Li, Y., Chang, L., Song, Y., Gao, X., Roselli, F., Liu, J., Zhou, W., Fang, Y., Wei, L., Li, H., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160297 · Cited by 37
Optical aptasensor based on silver nanoparticles for the colorimetric detection of adenosine
Yousefi, S., & Saraji, M. (2019) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2019.01.036 · Cited by 39
Therapeutic Potential of Agonists and Antagonists of A1, A2a, A2b and A3 Adenosine Receptors
Jamwal, S., Mittal, A., Kumar, P., Alhayani, D. M., & Al-Aboudi, A. F. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190716112319 · Cited by 39
Purinergic receptors in cognitive disturbances
Illés, P., Ulrich, H., Chen, J., & Tang, Y. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106229 · Cited by 38
Grković, I., Drakulić, D., Martinović, J., & Mitrović, N. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170518151541 · Cited by 37
Advances in protein misfolding, amyloidosis and its correlation with human diseases
Kundu, D., Prerna, K., Chaurasia, R., Bharty, M. K., & Dubey, V. K. (2020) · 3 Biotech · doi:10.1007/s13205-020-2166-x · Cited by 40
Zheng, S., Bai, Y.-Y., Liu, Y., Gao, X., Li, Y., Changyi, Y., Wang, Y., Chang, D., Ju, S., & Li, C. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.006 · Cited by 36
Modulating Alzheimer's Disease Through Caffeine: A Putative Link to Epigenetics
Marques, S., Batalha, V. L., Lopes, L. V., & Outeiro, T. F. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110032 · Cited by 36
Hohoff, C., Garibotto, V., Elmenhorst, D., Baffa, A., Kroll, T., Hoffmann, A., Schwarte, K., Zhang, W., Arolt, V., Deckert, J., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.150 · Cited by 36
Zhang, P., Bannon, N. M., Ильин, В. Н., Volgushev, M., & Chistiakova, M. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.279901 · Cited by 37
Li, S., Geiger, N. H., Soliman, M. L., Hui, L., Geiger, J. D., & Chen, X. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142223 · Cited by 35
Liu, L., Chen, Y., Luo, Q., Xu, N., Zhou, M., Gao, B., Wang, C., & Shi, Y. (2018) · LWT · doi:10.1016/j.lwt.2018.07.064 · Cited by 35
The retrotrapezoid nucleus and the neuromodulation of breathing
Moreira, T. S., Sobrinho, C. R., Falquetto, B., Oliveira, L. M., Lima, J. D., Mulkey, D. K., & Takakura, A. C. T. (2020) · Journal of Neurophysiology · doi:10.1152/jn.00497.2020 · Cited by 36
Modulation of neuroimmunity by adenosine and its receptors: Metabolism to mental illness
Chiu, G. S., & Freund, G. G. (2014) · Metabolism · doi:10.1016/j.metabol.2014.09.003 · Cited by 37
Adenosine production by brain cells
Jackson, E. K., Kotermanski, S. E., Menshikova, E. V., Dubey, R. K., Jackson, T. C., & Kochanek, P. M. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14018 · Cited by 33
Simola, N., Costa, G., & Morelli, M. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4130-8 · Cited by 33
Prasansuklab, A., & Tencomnao, T. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2340-4 · Cited by 33
Jakovljevic, M., Lavrnja, I. C., Bozic, I. D., Milosevic, A., Bjelobaba, I. M., Savić, D. Z., Sévigny, J., Peković, S., Nedeljković, N., & Laketa, D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00410 · Cited by 34
TME-targeted approaches of brain metastases and its clinical therapeutic evidence
Khan, I. M., Khan, S. U., Sala, H. S. S., Khan, M. U., Din, M. A. U., Khan, S., Hassan, S. S. U., Khan, N. M., & Liu, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1131874 · Cited by 31
The Adenosine Neuromodulation System in Schizophrenia
Rial, D., Lara, D. R., & Cunha, R. A. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00016-7 · Cited by 35
Self-citationPereira‐Figueiredo, D., Nascimento, A., Cunha-Rodrigues, M. C., Brito, R., & Calaza, K. D. C. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01077-4 · Cited by 35
Acute down‐regulation of adenosine A 1 receptor activity in status epilepticus
Hamil, N. E., Cock, H. R., & Walker, M. C. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03340.x · Cited by 32
Involvement of NMDA receptors in the antidepressant-like action of adenosine
Kaster, M. P., Machado, D. G., Santos, A. R. S., & Rodrigues, A. L. S. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70865-4 · Cited by 31
Self-citationHuntington’s Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers
Cybulska, K. A., Perk, L. R., Booij, J., Laverman, P., & Rijpkema, M. (2020) · Molecules · doi:10.3390/molecules25030482 · Cited by 30
Hohoff, C., Kroll, T., Zhao, B., Kerkenberg, N., Lang, I., Schwarte, K., Elmenhorst, D., Elmenhorst, E., Aeschbach, D., Zhang, W., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01085-w · Cited by 29
Gaudin, A., Lepêtre‐Mouelhi, S., Mougin, J., Parrod, M., Pieters, G., Garcia‐Argote, S., Loreau, O., Goncalves, J., Chacun, H., Courbebaisse, Y., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.016 · Cited by 30
Medina-Pulido, L., Molina‐Arcas, M., Justicia, C., Soriano, E., Burgaya, F., Planas, A. M., & Pastor‐Anglada, M. (2013) · Biochemical Journal · doi:10.1042/bj20130231 · Cited by 30
Cao, Z., Dai, D., Wei, P., Han, Y., Guan, Y., Li, H.-H., Liu, W.-X., Xiao, P., & Li, C. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.11.026 · Cited by 30
Durani, L. W., Hamezah, H. S., Ibrahim, N. F., Yanagisawa, D., Nasaruddin, M. L., Mori, M., Azizan, K. A., Damanhuri, H. A., Makpol, S., Ngah, W. Z. W., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170880 · Cited by 31
Molecular Dynamics Simulations of Adenosine Receptors: Advances, Applications and Trends
Al‐Shar’i, N. A., & Al-Balas, Q. A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190304123414 · Cited by 29
Lee, Y., Yang, Y.-C., Huang, C., Kuo, T.-Y., Lin, J., Yang, D., & Huang, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038865 · Cited by 31
The Antiepileptic Potential of Nucleosides
Kovács, Z., Kékesi, K. A., Juhász, G. D., & Dobolyi, Á. (2014) · Current Medicinal Chemistry · doi:10.2174/1381612819666131119154505 · Cited by 29
Naik, R. A., Mir, M. N., Malik, I. A., Bhardwaj, R., Alshabrmi, F. M., Mahmoud, M. A., Alhomrani, M., Alamri, A. S., Alsanie, W. F., Hjazi, A. M., et al. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl25551 · Cited by 29
The roles of purinergic signaling in psychiatric disorders.
Cieślak, M., Czarnecka, J., & Roszek, K. (2015) · Acta Biochimica Polonica · doi:10.18388/abp.2015_1004 · Cited by 29
Zhou, Q., Zhu, S., Guo, Y., Lian, L., Hu, Q. Z., Liu, X., Xu, F., Zhang, N., & Kang, H. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0571-x · Cited by 28
Yousefi, S., & Saraji, M. (2019) · Microchemical Journal · doi:10.1016/j.microc.2019.04.083 · Cited by 28
Adenosine Receptors in Modulation of Central Nervous System Disorders
Choudhury, H., Chellappan, D. K., Sengupta, P., Pandey, M., & Gorain, B. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190712181955 · Cited by 27
Caffeine regulates GABA transport via A1R blockade and cAMP signaling
Borges-Martins, V. P. P., Ferreira, D. D. P., Souto, A. C., Neto, J. G. O., Pereira‐Figueiredo, D., Calaza, K. D. C., Oliveira, K. J., Manhães, A. C., Reis, R. A. D. M., & Kubrusly, R. C. C. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104550 · Cited by 27
Adenosine as a Key Mediator of Neuronal Survival in Cerebral Ischemic Injury
Khan, H., Kaur, P., Singh, T. G., Grewal, A. K., & Sood, S. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03737-3 · Cited by 26
Kanno, T., & Nishizaki, T. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000343328 · Cited by 27
Andrews, S. P., & Tehan, B. G. (2012) · MedChemComm · doi:10.1039/c2md20164j · Cited by 27
Adenosine and adenosine receptors in metabolic imbalance-related neurological issues
Jang, M., & Song, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116996 · Cited by 30
Aboumanei, M. H., & Mahmoud, A. F. (2020) · Process Biochemistry · doi:10.1016/j.procbio.2020.07.018 · Cited by 26
Myelin Defects in Niemann–Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives
Bernardo, A., Nuccio, C. D., Visentin, S., Martire, A., Minghetti, L., Popoli, P., & Ferrante, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168858 · Cited by 27
Jones, N. S., Watson, K. Q., & Rebeck, G. W. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02256-2 · Cited by 26
Li, X., Kang, H., Liu, X., Liu, Z., Shu, K., Chen, X., & Zhu, S. (2012) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-012-0046-2 · Cited by 26
Modulation of synaptic transmission by adenosine in layer 2/3 of the rat visual cortex in vitro
Bannon, N. M., Zhang, P., Ильин, В. Н., Chistiakova, M., & Volgushev, M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.12.018 · Cited by 26
Modulation of adenosinergic system and its application for the treatment of epilepsy
Świąder, M., Kotowski, J., & Łuszczki, J. J. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.10.005 · Cited by 26
Du, H., Li, C., Gao, R., Tan, Y. H., Wang, B., Peng, Y., Yang, N., Ning, Y., Li, P., Zhao, Y., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14408 · Cited by 24
Disturbances of purinergic system in affective disorders and schizophrenia
Malewska-Kasprzak, M., Permoda‐Osip, A., & RYBAKOWSKI, J. K. (2019) · Psychiatria Polska · doi:10.12740/pp/97335 · Cited by 28
Aires, I. D., Madeira, M. H., Boia, R., Rodrigues‐Neves, A. C., Martins, J., Ambrósio, A. F., & Santiago, A. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-53627-y · Cited by 25
Siebel, A. M., Piato, Â., Schaefer, I. C., Nery, L. R., Bogo, M. R., & Bonan, C. D. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.021 · Cited by 25
Nedeljković, N. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.007 · Cited by 27
Adenosine A2B receptor activation stimulates glucose uptake in the mouse forebrain
Lemos, C., Pinheiro, B. S., Beleza, R. O., Marques, J. M., Rodrigues, R. J., Cunha, R. A., Rial, D., & Köfalvi, A. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9474-3 · Cited by 24
Self-citationKovács, Z., Kékesi, K. A., Juhász, G. D., Barna, J., Héja, L., Lakatos, R. K., & Dobolyi, Á. (2015) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557514666141107120226 · Cited by 24
He, X., Chen, F., Zhang, Y., Gao, Q., Guan, Y., Wang, J., Zhou, J., Zhai, F., Boison, D., Luan, G., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12770 · Cited by 23
Shi, Y., Dai, Q., Ji, B., Huang, L., Zhuang, X., Mo, Y., & Wang, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.680706 · Cited by 23
Ping, C., Lu, Y., Lin, Y.-H., Wu, C.-P., Tang, C.-K., Wei, S.-C., & Wu, Y. (2021) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2021.103674 · Cited by 29
Puzio, M., Moreton, N., & O'Connor, J. J. (2022) · Brain Disorders · doi:10.1016/j.dscb.2022.100030 · Cited by 23
A2A Adenosine Receptor Antagonists and their Potential in Neurological Disorders
Lambertucci, C., Marucci, G., Catarzi, D., Colotta, V., Francucci, B., Spinaci, A., Varano, F., & Volpini, R. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220218094501 · Cited by 23
Recent insights into mechanisms of hypoxia‐induced vasodilatation in the human brain
Carr, J. M. J. R., Hoiland, R. L., Fernandes, I. A., Schrage, W. G., & Ainslie, P. N. (2023) · The Journal of Physiology · doi:10.1113/jp284608 · Cited by 23
Ye, Y., Li, J., Cao, X., Chen, Y., Ye, C., & Chen, K. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.04.046 · Cited by 23
Betti, M., Catarzi, D., Varano, F., Falsini, M., Varani, K., Vincenzi, F., Pasquini, S., Mannelli, L. D. C., Ghelardini, C., Lucarini, E., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00106 · Cited by 23
The possible role of the nucleoside adenosine in countering skin aging: A review
Marucci, G., Buccioni, M., Varlaro, V., Volpini, R., & Amenta, F. (2022) · BioFactors · doi:10.1002/biof.1881 · Cited by 24
Zhou, X., Khanapur, S., de Jong, J. R., Willemsen, A. T. M., Dierckx, R., Elsinga, P. H., & de Vries, E. F. J. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16634714 · Cited by 22
Caffeine Protects Against Anticonvulsant-Induced Impaired Neurogenesis in the Developing Rat Brain
Endesfelder, S., Weichelt, U., Schiller, C., Winter, K., von Haefen, C., & Bührer, C. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9872-8 · Cited by 22
Pharmacological Therapies for Machado-Joseph Disease
Duarte‐Silva, S., & Maciel, P. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-71779-1_19 · Cited by 22
Murray, I. V. J., Bass, B., Upson, S., Roy, K., Montgomery, E., & Jalonen, T. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.160059 · Cited by 21
Samadi, M., Shaki, F., Bameri, B., Fallah, M., Ahangar, N., & Mohammadi, H. (2019) · Drug and Chemical Toxicology · doi:10.1080/01480545.2019.1643874 · Cited by 21
Zebrafish models: Gaining insight into purinergic signaling and neurological disorders
Nabinger, D. D., Altenhofen, S., & Bonan, C. D. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109770 · Cited by 21
Huang, S., Su, Z.-Y., Han, Y., Liu, L., Shang, Y., Mai, Z.-F., Zeng, Z.-W., & Li, C. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154649 · Cited by 21
Federico, S., Ciancetta, A., Porta, N., Redenti, S., Pastorin, G., Cacciari, B., Klotz, K., Moro, S., & Spalluto, G. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.12.019 · Cited by 21
Vala, C., Morley, T. J., Zhang, X., Papin, C., Tavares, A., Lee, H. S., Constantinescu, C. C., Barret, O., Carroll, V. M., Baldwin, R. M., et al. (2016) · ChemMedChem · doi:10.1002/cmdc.201600219 · Cited by 21
Cheng, P., Ren, Y., Bai, S., Wu, Y. H., Xu, Y., Pan, J., Chen, J., Zhu, X., Qi, Z., Shao, W., et al. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0208-4 · Cited by 21
Amorim, B. O., Hamani, C., Ferreira, E. S., Miranda, M. F., Fernandes, M. J. D. S., Rodrigues, A. M., de Almeida, A.-C. G., & Covolan, L. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.05.036 · Cited by 21
Miranda‐Lourenço, C., Duarte, S. T., Palminha, C., Gaspar, C., Rodrigues, T. M., Magalhães-Cardoso, M. T., Rei, N., Colino-Oliveira, M., Gomes, R., Ferreira, S. G. F., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105043 · Cited by 20
Understanding the Role of Glia-Neuron Communication in the Pathophysiology of Epilepsy: A Review
Chen, P., Chen, F., & Zhou, B. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2104102 · Cited by 20
The role of adenosine A1 receptor on immune cells
Zhong, L., Peng, Q., & Zeng, X. (2022) · Inflammation Research · doi:10.1007/s00011-022-01607-w · Cited by 22
Ahn, W., Chi, G., Kim, S., Son, Y., & Zhang, M. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01284-7 · Cited by 20
Malik, H., Usman, M., Arif, M., Ahmed, Z. S., Ali, G., Rauf, K., & Sewell, R. D. E. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1232088 · Cited by 20
The altered TBI fecal microbiome is stable and functionally distinct
Pyles, R. B., Miller, A. L., Urban, R. J., Sheffield‐Moore, M., Wright, T. J., Maxwell, C. A., Randolph, K. M., Danesi, C. P., McGovern, K. A., Vargas, J., et al. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1341808 · Cited by 20
Komaki, S., Ishikawa, K., & Arakawa, Y. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.06.003 · Cited by 20
Zimmermann, F. F., Gaspary, K. V., Siebel, A. M., Leite, C. E., Kist, L. W., Bogo, M. R., & Bonan, C. D. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9917-z · Cited by 23
Xeronine structure and function: computational comparative mastery of its mystery
Sanni, D. M., Fatoki, T. H., Kolawole, A. O., & Akinmoladun, A. C. (2017) · In Silico Pharmacology · doi:10.1007/s40203-017-0028-y · Cited by 20
Structure and Regulation of Glycogen Synthase in the Brain
Pederson, B. A. (2019) · Advances in neurobiology · doi:10.1007/978-3-030-27480-1_3 · Cited by 22
Neurochemical Measurement of Adenosine in Discrete Brain Regions of Five Strains of Inbred Mice
Pani, A. K., Jiao, Y., Sample, K. J., & Smeyne, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092422 · Cited by 20
Does caffeine therapy improve cognitive impairments in valproic acid rat model of autism?
Rajizadeh, M. A., Afarinesh, M. R., Zarif, M., Mirasadi, A., & Esmaeilpour, K. (2019) · Toxin Reviews · doi:10.1080/15569543.2019.1680563 · Cited by 19
Wu, C.-Y., Liang, C.-H., & Liang, Z. (2021) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2021.11.005 · Cited by 19
Bhat, J. A., & Kumar, M. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00995-6 · Cited by 19
Metadata
- Authors
- Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A.
- Affiliations
- University of Coimbra (PT)
- Corresponding author
- Cunha, Rodrigo A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 1808
- Issue
- 5
- Pages
- 1380-1399
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W2081196843
- Cited by
- 419
- References
- 473
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 15 · 2023: 21 · 2022: 30 · 2021: 24 · 2020: 37 · 2019: 43 · 2018: 36 · 2017: 30 · 2016: 27 · 2015: 38 · 2014: 32 · 2013: 22 · 2012: 26
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Biomembranes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundação para a Ciência e a Tecnologia
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- adenosine receptors, adenosine A1 receptor, adenosine A2A receptor, neuroprotection, neurodegeneration, neuromodulation, glutamatergic synapses, synaptic plasticity, ischemia, epilepsy, Parkinson's disease, Alzheimer's disease, neuroinflammation, neuron-glia communication, neurogenesis, growth factors, mental illness, adenosine receptor agonists
- MeSH terms
- Animals, Brain Diseases, Humans, Nerve Degeneration, Receptors, Purinergic P1, Neurotransmitter Agents, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review